Literature DB >> 31760956

Pleural effusion as an atypical presentation of Kawasaki disease: a case report and review of the literature.

Elif Arslanoglu Aydin1, Selcan Demir2, Orkun Aydin3, Yelda Bilginer2, Seza Ozen4.   

Abstract

BACKGROUND: Kawasaki disease is an acute, febrile vasculitis of childhood that affects medium-sized arteries, predominantly the coronary arteries. It is a multisystem disease; therefore, it may present with non-cardiac findings of disease. CASE
PRESENTATION: Here, we report the case of 7-year-old Turkish girl who presented with symptoms of fever, chest pain, and vomiting, who was diagnosed as having Kawasaki disease. We also present a literature review on pulmonary involvement due to Kawasaki disease.
CONCLUSION: Pediatricians should consider the diagnosis of Kawasaki disease in the presence of pneumonia and pleural effusion that is nonresponsive to antibiotic therapy. This will prevent delay in diagnosis and the adverse consequences of the disease.

Entities:  

Keywords:  Kawasaki disease; Pleural effusion; Pulmonary involvement

Mesh:

Substances:

Year:  2019        PMID: 31760956      PMCID: PMC6876070          DOI: 10.1186/s13256-019-2284-4

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


Background

Kawasaki disease (KD) is one of the most common vasculitis disorders of childhood [1]. Although it is a multisystem disease that mainly affects the coronary arteries, it can, rarely, present with unusual system involvement of the pulmonary system, gastrointestinal tract, central nervous system, and genitourinary system [1]. Here, we report the case of a patient with KD who presented with an unusual form of pleural effusion. We also present a literature review on the subject.

Case presentation

A 7-year-old Turkish girl presented to a local hospital with fever, chest pain, and vomiting. At hospital admission, she was febrile with a respiratory rate of 50 per minute. On physical examination, auscultation of her lungs revealed diminished breath sounds of the lower lobe of her left lung. An anteroposterior (AP) chest X-ray and chest ultrasonography showed a left lower lobar consolidation with minimal pleural effusion. She was hospitalized and sulbactam ampicillin (SAM), ceftriaxone, and clarithromycin were initiated. On the third day, her condition worsened with increasing pleural effusion (Fig. 1). Thoracentesis was performed. SAM and ceftriaxone treatments were discontinued and meropenem and vancomycin were started. A chest tube was inserted and 130 mL of pus was drained. Light’s criteria were positive for an exudative pleural effusion; a pleural fluid culture was sterile. After 4 days, the chest tube was removed. High fever persisted for 15 days despite broad spectrum antibiotics, and acute-phase reactants remained high; therefore, she was referred to our hospital for further evaluation.
Fig. 1

Chest X-ray of the patient showing left lower lobar consolidation with pleural effusion

Chest X-ray of the patient showing left lower lobar consolidation with pleural effusion She had a fever with a temperature of 38.1 °C, her respiratory rate was 48/minute, heart rate was 125/minute, blood pressure was 90/65 mm Hg, and oxygen saturation was 95%. A physical examination revealed non-purulent conjunctivitis in both eyes, perianal peeling, and periungual desquamation on her hand, fingers, and toes. All other findings in the physical examination were unremarkable. She had unilateral cervical lymphadenopathy and a rash on her extremities while in the other hospital. Her past medical history was unremarkable, as was her family history. Immunizations were up-to-date for her age. On admission to our hospital, the laboratory findings were as follows: hemoglobin 10.2 g/dL, white blood cells 14,000/μL, and platelets 736,000/μL. C-reactive protein (CRP) was 4.26 mg/dL (normal, 0–0.8 mg/dL), the erythrocyte sedimentation rate (ESR) was 42 mm/hour (normal, 0–20 mm/hour), and the albumin, creatinine, aspartate aminotransferase, alanine aminotransferase, gamma glutamyl transferase, blood urea nitrogen, calcium, sodium, chloride, and potassium levels were normal. Urine analysis was normal. A chest X-ray was normal. Perivascular brightness and echogenicity of her right coronary artery was noted on transthoracic echocardiography (TTE). She was diagnosed as having KD based on the presence of fever, bilateral non-purulent conjunctivitis, cervical adenopathy, perianal peeling, periungual desquamation, elevated acute-phase reactants (ESR, CRP), thrombocytosis, and coronary artery involvement (CAI). Intravenous immunoglobulin (IVIG) (2 g/kg, infusion in 12 hours) and acetylsalicylic acid (60 mg/kg per day) were initiated. The fever resolved after IVIG infusion. At a 3-month follow-up visit, the acute-phase reactants and a TTE were normal. One year after the diagnosis, a TTE was normal and she was perfectly healthy.

Discussion and conclusion

The most important complication of KD is CAI, which leads to enlargement, aneurysm, ischemic heart disease, and sudden death [1]. The clinical course of KD is highly variable. There are no pathognomonic clinical or laboratory findings to help diagnose KD. The diagnosis of KD in this case was made using the criteria of the American Heart Association [1]. In the presence of at least 5 days of fever, if there are at least four of the five principal criteria (cervical adenopathy, bilateral non-purulent conjunctivitis, oropharyngeal mucosal changes, polymorphous rash, erythema of the palms or soles, and edema of the hands or feet) the patient is diagnosed as having KD [1]. KD may present with uncommon symptoms such as pneumonia, pleural effusion, diarrhea, vomiting, sterile pyuria, gallbladder hydrops, acute cholestatic hepatitis, arthritis, and aseptic meningitis [2-7]. Pulmonary system involvement of KD is very rare; KD can present as pneumonia, pulmonary nodules, bronchopneumonia, hydropneumothorax, and pleural effusion [6, 8, 9]. Singh et al. showed that 1.3% of patients had pulmonary involvement and pleural effusion was seen in 54.5% of these patients [6]. Ugi et al. reported the case of an adult patient who presented with pulmonary involvement, specifically bilateral massive pleural effusions [10]. Occasionally, pleural effusion may be associated with bacterial agents such as Mycoplasma pneumoniae and Streptococcus [11, 12]. Pulmonary symptoms are mostly initially treated with antibiotics. However, if fever and accompanying signs ensue, the diagnosis of KD should be considered. Patients with pulmonary involvement may be more likely to have CAI due to delays in diagnosing KD and administration of IVIG [12-17]. We performed a review of the literature using PubMed and the search terms: Kawasaki disease AND pulmonary involvement; OR Kawasaki disease AND pulmonary presentation; OR Kawasaki disease AND pleural effusion. The searches were limited to the English language and pediatric patients. Case series and single case reports involving pediatric patients with KD with pulmonary involvement were included. Inconsistencies were resolved through discussion with the author SO, who also reviewed the literature. The authors EAA and OA searched the literature and manually screened titles and abstracts for relevance. Inconsistencies were resolved through discussion with the author SO. Figure 2 lists the schematic analyses of the systematic literature review. At first, 25 related articles were found, but nine articles were excluded because of duplication, non-English language, and adult age, which left 16 articles [6, 8, 11–24]. The characteristics of these patients are summarized in Tables 1, 2, and 3. Finally, 20 patients with pleural effusions due to KD were identified [6, 11–18, 20, 24]. Of the 20 reviewed patients, TTE results were available in nine patients and seven had CAI [6, 12–17, 24]. Eleven patients presented with respiratory symptoms such as cough, dyspnea, and tachypnea [6, 12–15, 20]. Only four patients [14, 17, 18, 24] had complete KD, 10 patients [6, 13, 15, 16, 20] had incomplete KD, and six patients’ [11, 12] presentations were not available. Although a definite infectious agent could be shown for two patients [18, 24], all of the patients received antibiotics except one [14]. Two patients [6, 17] received a second dose of IVIG, and five patients received a second dose of IVIG and corticosteroid treatment for KD [13–16, 18].
Fig. 2

Study flowchart

Table 1

Clinical symptoms and laboratory parameters of patients who had pulmonary involvement associated with Kawasaki disease

Authors, year, reference numberRashOral changesExtremity changesRed eyesAdenitisOther clinical symptomsHb (g/dL)WBC (/mm3)Plt (/mm3)CRP (mg/dL)ESR (mm/hour)
Singh et al., 2018, [6]5a1 a8a1 a0 a

Perianal desquamation, 3 a;

irritability, 1 a

NA25,009b886,545b14.05c53.75 d
Alhammadi and Hendaus, 2013, [12]NANANANANANANA24,000600,0001065
Lee et al., 2011, [11]NANANANANANANANANANANA
Lee et al., 2010, [14]YesYesYesYesYesPerianal desquamationNA5500178,0002.821
Falcini et al., 2009, [15]NoNoNoYesNoIrritability9.521,800710,00027.899
Elizabeth et al., 2007, [16]NoYesYesNoYesIrritability10.212,800550,0007.786
Yavuz et al., 2007, [17]YesYesYesYesNoNon-pigmented keratic precipitates in both of the patient’s eyes, sterile pyuria10.432,800734,00021.890
Sittiwangkul and Pongprot, 2004, [13]YesNoYesYesNoIrritabilityNA21,200231,0004.7766
de Magalhães et al., 2012, [21]YesYesYesYesNoInduration at the BCG site, perianal desquamation6.525,000905,00034120
Hamada et al., 2005, [18]YesYesYesNoYesHepatomegalyNA17,800NA13.9NA
D'Souza et al., 2006, [20]NoNoYesNoYesSterile pyuria9.856,800690,000NA138
de Maddi et al., 2009, [22]
 Case 1NoYesNoYesYesNo8.711,200561,00010.470
 Case 2NoNoNoNoNoNo926,960142,00040.8107
 Case 3YesYesNoYesNoIrritability, sterile pyuria1118,5001,087,0002.9550
Freeman et al., 2003, [23]
 Case 1YesYesNoYesNoIrritabilityNANA1,120,000NANA
 Case 2NoYesNoYesYesTorticollisNANA1,102,000NA114
 Case 3YesNoNoNoYesAnorexiaNANA450,00010.5NA
Kobayashi et al., 2006, [24]
 Case 1YesYesNoYesYes9.613,000321,00012.6102
 Case 2YesYesYesYesNoInduration at the BCG site11.618,800314,0007.6NA
Vaidya et al., 2017, [8]YesYesYesNoNo8.915,600567,0005.640
Akagi et al., 2017, [19]
 Case 1YesYesYesNoNoNANANA4.26NA
 Case 2YesYesNoNoNoNANANA4.32NA

aNumber of the patients who had the symptom

b,c,dValues are expressed as mean for 11, 8, and 10 patients, respectively

BCG Bacille Calmette–Guérin, CRP C-reactive protein, ESR erythrocyte sedimentation rate, Hb hemoglobin, NA not available, Plt platelet, WBC white blood cell

Table 2

Demographic parameters and clinical presentations of patients who had pulmonary involvement associated with Kawasaki disease

Authors, year, reference numberPatients (n)SexAge at onset of disease (months)Initial symptomsFever duration (days)Chest X-ray findings
Singh et al., 2018, [6]11

F, 6 a;

M, 5 a

30 bFever, cough, tachypnea14.1 b

Consolidation,11 a; pleural effusion,6 a;

empyema, 3 a; pneumothorax, 2 a

Alhammadi and Hendaus, 2013, [12]1F36Fever, cough, sore throat18Consolidation, pleural effusion
Lee et al., 2011, [11]54NANANANA

Reticulonodular,17 a; opacification, 34 a; consolidation, 12 a; pleural effusion, 5 a

diffuse interstitial, 5 a; atelectasis, 2 a;

Lee et al., 2010, [14]1M22Fever, cough, rhinorrhea6Infiltration, pleural effusion
Falcini et al., 2009, [15]1F30Fever, cough,12Pleural effusion
Elizabeth et al., 2007, [16]1F36Fever, gum bleeding21Pleural effusion
Yavuz et al., 2007, [17]1M11Fever, pharyngeal erythema, dyspnea> 5Pleural effusion
Sittiwangkul and Pongprot, 2004, [13]1F11Fever, jaundice, diarrhea, dyspnea15Pleural effusion
de Magalhães et al., 2012, [21]1F3Fever10Infiltration
Hamada et al., 2005, [18]1F60Fever, abdominal pain, knee joint pain15Pleural effusion
D'Souza et al., 2006, [20]1M5Fever, diarrhea, dyspnea7Pleural effusion
 Case 11M8Fever, sore throat8Consolidation
 Case 21F11Febrile seizure, sore throat, cough14Consolidation
 Case 31F23Fever, cough10Consolidation
Freeman et al., 2003, [23]
 Case 11M4Fever, cough, rash21NA
 Case 21M6Fever60

Normal;

thorax CT, pulmonary nodule

 Case 31NA5Fever cough, rash4Infiltration, multiple pulmonary nodules
Kobayashi et al., 2006, [24]
 Case 11F24Fever, cracked lips, rash5Infiltration, pleural effusion
 Case 21F24Fever, cough, nasal discharge4Atelectasis
Vaidya et al., 2017, [8]1F3Fever, rash, dyspnea32Hydropneumothorax, consolidation, pneumatoceles
Akagi et al., 2017, [19]
 Case 11F4Fever, erythema of the lips, rashNA

NA;

thorax MRI, bilateral multiple

pulmonary nodules

 Case 21F5Fever, erythema of the lips, rash9

Infiltration;

thorax CT, bilateral pulmonary nodules

aNumber of the patients who had noted findings

bValues are expressed as mean for 11 patients

CT computed tomography, F female, M male, MRI magnetic resonance imaging, NA not available

Table 3

Treatment, coronary artery involvement, follow-up, and outcomes of patients who had pulmonary involvement associated with Kawasaki disease

Authors, year, reference numberInfectious agentAntibiotic treatmentCAITreatmentFollow-up and outcome
Singh et al., 2018, [6]2 a11 a3 a2 a, Second dose of IVIG9 a Normal, 2 a NA
Alhammadi and Hendaus, 2013, [12]NoYesYesIVIGNormal
Lee et al., 2011, [11]NANANANANA
Lee et al., 2010, [14]NoNoYesSecond dose of IVIG and corticosteroidNormal
Falcini et al., 2009, [15]NoYesYesSecond dose of IVIG and corticosteroidNormal
Elizabeth et al., 2007, [16]NoYesYesSecond dose of IVIG and corticosteroidNormal
Yavuz et al., 2007, [17]NoYesYesSecond dose of IVIGNormal
Sittiwangkul and Pongprot, 2004, [13]NoYesYesSecond dose of IVIG and corticosteroidAneurysm persisted in 2 years
de Magalhães et al., 2012, [21]NoYesYesSecond dose of IVIG, corticosteroid, MTX, and ETNAneurysm decrease but persisted
Hamada et al., 2005, [18]NoYesNoSecond dose of IVIG and corticosteroidNormal
D'Souza et al., 2006, [20]NoYesNoIVIGNormal
de Maddi et al., 2009, [22]
 Case 1NoYesNoIVIGNormal
 Case 2NoYesNoNot given IVIGNormal
 Case 3NoYesNoIVIGNormal
Freeman et al., 2003, [23]
 Case 1NoYesYesIVIGDeath
 Case 2NAYesYesIVIGNormal
 Case 3NoYesYesIVIGNormal
Kobayashi et al., 2006, [24]
 Case 1YesYesNAIVIGNormal
 Case 2YesYesNAIVIGNormal
Vaidya et al., 2017, [8]NoYesYesIVIGNA
Akagi et al., 2017, [19]
 Case 1NoNoYesIVIGNormal
 Case 2NoYesYesIVIGNormal

aNumber of the patients

CAI coronary artery involvement, ETN etanercept, IVIG intravenous immunoglobulin, MTX methotrexate, NA not available

Study flowchart Clinical symptoms and laboratory parameters of patients who had pulmonary involvement associated with Kawasaki disease Perianal desquamation, 3 ; irritability, 1 aNumber of the patients who had the symptom b,c,dValues are expressed as mean for 11, 8, and 10 patients, respectively BCG Bacille Calmette–Guérin, CRP C-reactive protein, ESR erythrocyte sedimentation rate, Hb hemoglobin, NA not available, Plt platelet, WBC white blood cell Demographic parameters and clinical presentations of patients who had pulmonary involvement associated with Kawasaki disease F, 6 ; M, 5 Consolidation,11 ; pleural effusion,6 ; empyema, 3 ; pneumothorax, 2 Reticulonodular,17 ; opacification, 34 ; consolidation, 12 ; pleural effusion, 5 diffuse interstitial, 5 ; atelectasis, 2 ; Normal; thorax CT, pulmonary nodule NA; thorax MRI, bilateral multiple pulmonary nodules Infiltration; thorax CT, bilateral pulmonary nodules aNumber of the patients who had noted findings bValues are expressed as mean for 11 patients CT computed tomography, F female, M male, MRI magnetic resonance imaging, NA not available Treatment, coronary artery involvement, follow-up, and outcomes of patients who had pulmonary involvement associated with Kawasaki disease aNumber of the patients CAI coronary artery involvement, ETN etanercept, IVIG intravenous immunoglobulin, MTX methotrexate, NA not available In this case, our patient initially had an exudative, noninfectious pleural effusion and no response to antibiotics. CAI was also noticed and IVIG was administered on the 15th day of fever. After IVIG treatment, our patient’s clinical and laboratory findings improved dramatically, and the fever and acute-phase reactants returned to normal. It remains unclear as to whether the KD was triggered by the infection of the pleural space or if the pulmonary finding was a feature of the inflammation of KD. KD can affect various systems as well as the coronary arteries, and may present with an unusual clinical picture. The diagnosis of KD with atypical presentations may be difficult for pediatricians. Early diagnosis and treatment can prevent complications.
  24 in total

1.  Large pleural effusion: an unusual manifestation of Kawasaki disease.

Authors:  Rekwan Sittiwangkul; Yupada Pongprot
Journal:  Clin Pediatr (Phila)       Date:  2004-05       Impact factor: 1.168

2.  Marked pleural and pericardial effusion with elevated Vascular Endothelial Growth Factor production: an uncommon complication of Kawasaki disease.

Authors:  Hiromichi Hamada; Masaru Terai; Takafumi Honda; Yoichi Kohno
Journal:  Pediatr Int       Date:  2005-02       Impact factor: 1.524

3.  Case 2: fever, rash and pulmonary involvement. Diagnosis: Kawasaki disease.

Authors:  Yuki Kobayashi; Yuji Koike; Tomoharu Tokutomi; Yasutomi Kuroki; Isao Todoroki
Journal:  Acta Paediatr       Date:  2006-09       Impact factor: 2.299

4.  Refractory pneumonia and high fever.

Authors:  Fernanda Falcini; Agata Vitale; Francesco La Torre; Giovanni Conti; Carmelo Fede; Giuseppina Calcagno
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

5.  Pleural effusion and disseminated intravascular coagulopathy: the rarely reported complications of kawasaki disease.

Authors:  Sun Hyang Lee; You Hoon Jeon; Hyeon Jong Yang; Bok Yang Pyun
Journal:  Clin Pediatr (Phila)       Date:  2010-01-13       Impact factor: 1.168

6.  Two cases of Kawasaki disease presented with acute febrile jaundice.

Authors:  Ayşe Kaman; Türkan Aydın-Teke; Zeynep Gökçe Gayretli-Aydın; Fatma Nur Öz; Özge Metin-Akcan; Deniz Eriş; Gönül Tanır
Journal:  Turk J Pediatr       Date:  2017       Impact factor: 0.552

Review 7.  Gallbladder Hydrops Associated With Kawasaki Disease: A Case Report and Literature Review.

Authors:  Qiufeng Sun; Jianmin Zhang; Yungang Yang
Journal:  Clin Pediatr (Phila)       Date:  2017-03-01       Impact factor: 1.168

8.  Atypical relapsing course of Kawasaki disease with hemorrhagic serous effusions and hepatic dysfunction.

Authors:  K E Elizabeth; M Zulfikar Ahamed; K S Praveen
Journal:  Indian Pediatr       Date:  2007-10       Impact factor: 1.411

9.  Mycoplasma pneumoniae infection in patients with Kawasaki disease.

Authors:  Mi Na Lee; Jie Hae Cha; Hye Mi Ahn; Jeong Hyun Yoo; Hae Soon Kim; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2011-03-31

Review 10.  Controversies in diagnosis and management of Kawasaki disease.

Authors:  Rakesh Kumar Pilania; Dharmagat Bhattarai; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2018-02-08
View more
  1 in total

Review 1.  Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature.

Authors:  Krishan Pratap; Logan S Gardner; David Gillis; Martin Newman; Dana Wainwright; Roger Prentice
Journal:  BMC Gastroenterol       Date:  2020-10-27       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.